Investing

Venrock Healthcare Takes Significant Position in SVRA / Savara

seksan mongkhonkhamsao / Getty Images

Fintel reports that Venrock Healthcare Capital Partners II, L.P. has filed a 13G form with the SEC disclosing ownership of 6,187,282 shares of Savara Inc (SVRA). This represents 5.4% of the company.

Savara is an orphan lung disease company. Its lead program, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Its management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.

What are other large shareholders doing?

NEA Management Company, LLC holds 24,137,931 shares representing 21.17% ownership of the company. No change in the last quarter.

Bain Capital Life Sciences Investors, LLC holds 11,622,598 shares representing 10.19% ownership of the company. No change in the last quarter.

Farallon Capital Management Llc holds 9,908,086 shares representing 8.69% ownership of the company. In it’s prior filing, the firm reported owning 9,577,273 shares, representing an increase of 3.34%. The firm increased its portfolio allocation in SVRA by 1.92% over the last quarter.

Caxton Corp holds 6,896,551 shares representing 6.05% ownership of the company. No change in the last quarter.

Adage Capital Partners Gp, L.l.c. holds 6,864,551 shares representing 6.02% ownership of the company. No change in the last quarter.

What is the overall institutional sentiment?

There are 77 funds or institutions reporting positions in Savara Inc. This is a decrease of 2 owner(s) or 2.53%.

Average portfolio weight of all funds dedicated to Savara Inc is 0.2469%, an increase of 36.2611%. Total shares owned by institutions increased in the last three months by 1.73% to 77,788,692 shares.

This article originally appeared on Fintel

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans  set to retire this year, you may want to pay attention.

Finding a financial advisor who puts your interest first can be the difference between a rich retirement and barely getting by, and today it’s easier than ever. SmartAsset’s free tool matches you with up to three fiduciary financial advisors that serve your area in minutes. Each advisor has been carefully vetted, and must act in your best interests. Start your search now.

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.